Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Starboard Value, an activist investor, has reportedly acquired a substantial stake in Kenvue Inc KVUE, the company behind popular consumer products like Tylenol and Listerine. Despite having some ...
Results that may be inaccessible to you are currently showing.